Pluri Inc. Logo

Pluri Inc.

PLUR | TA

Overview

Corporate Details

ISIN(s):
US72942G2030
LEI:
Country:
Israel
Address:
Park Building No. 5, 3508409 Haifa
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Pluri develops cell-based therapeutic solutions, focusing on regenerative medicine and tissue repair, headquartered in Israel.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Pluri Inc.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-03 22:43
Post-Annual General Meeting Information
Immediate Report
Hebrew (modern) 224.6 KB
2025-07-03 22:43
Foreign Filer Report
Immediate Report
English 36.5 KB
2025-07-02 01:15
Director's Dealing
Other Report or Announcement
English 267.8 KB
2025-07-02 01:15
Foreign Filer Report
Other Report or Announcement
English 36.4 KB
2025-05-28 21:57
Proxy Solicitation & Information Statement
mediate Report of Meeting to be held on June 30, 2025
English 1.4 MB
2025-05-28 21:57
Pre-Annual General Meeting Information
mediate Report of Meeting to be held on June 30, 2025
English 184.6 KB
2025-05-28 01:52
Annual Report
Materials for Annual Meeting - Annual Report for 30.06.2024
English 346.4 KB
2025-05-28 01:52
Foreign Filer Report
Materials for Annual Meeting - Annual Report for 30.06.2024
English 36.3 KB
2025-05-28 01:36
Proxy Solicitation & Information Statement
Immediate Report of Meeting to be held on June 30, 2025, proxy
English 1.4 MB
2025-05-28 01:36
Pre-Annual General Meeting Information
Immediate Report of Meeting to be held on June 30, 2025, proxy
English 161.1 KB
2025-05-27 17:56
Pre-Annual General Meeting Information
FORM 8K – Updated Regurding Annual Meeting Date
English 112.3 KB
2025-05-27 17:56
Foreign Filer Report
FORM 8K – Updated Regurding Annual Meeting Date
English 36.3 KB
2025-05-20 17:26
Major Shareholding Notification
Form 13D/A-Yaky Yanay
English 168.9 KB
2025-05-20 17:26
Foreign Filer Report
Form 13D/A-Yaky Yanay
English 36.2 KB
2025-05-15 16:02
Management Discussion and Analysis
Pluri CEO Issues Shareholder Letter
English 110.5 KB

Automate Your Workflow. Get a real-time feed of all Pluri Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Pluri Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
HEMOGENYX PHARMACEUTICALS PLC Logo HEMOGENYX PHARMACEUTICALS PLC United Kingdom HEMO
Herantis Pharma Oyj Logo Herantis Pharma Oyj Finland HRTIS
Hiron-Trade Investments & Industrial Buildings Ltd. Israel HRON
Human Stem Cells Institute PJSC Logo Human Stem Cells Institute PJSC Russian Federation ISKJ
Human Xtensions Ltd. Logo Human Xtensions Ltd. Israel HUMX
Hybrigenics SA Logo Hybrigenics SA France ALHYG
Hyloris Pharmaceuticals SA Logo Hyloris Pharmaceuticals SA Belgium HYL
Ikonisys S.A. Logo Ikonisys S.A. France ALIKO
IMCB PJSC Logo IMCB PJSC Russian Federation GEMA
Immunic AG Logo Immunic AG United States of America IMUX